Kubota Vision, the American subsidiary of the Japanese-based Kubota Pharmaceutical Holdings, last month enrolled its first patient for a clinical study aimed at controlling the development of myopia. Two months ago, the company reported positive results on a first research where myopically defocused images were projected by electronic tabletop devices on the peripheral retina of 12 patients. The company believes that its technology could prevent myopia in children and is launching its new research to validate that similar results can be achieved with a wearable device. The new clinical tests will include 25 patients and take place at the Manhattan Vision Associates / Institute for Vision Research in New York. Kubota Vision is planning to complete this round of research and make a smart glasses’ prototype available before the end of this year. The company is also working on the integration of the technology in smart contact lenses.